Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

被引：0
|
作者：
Akiko Ogiya
Kieko Yamazaki
Rie Horii
Tadahiko Shien
Yoshiya Horimoto
Norikazu Masuda
Touko Inao
Mitsuchika Hosoda
Naoko Ishida
Tomofumi Osako
Masato Takahashi
Yumi Endo
Yuichiro Miyoshi
Hiroyuki Yasojima
Nobumoto Tomioka
Hiroko Yamashita
机构：
[1] Japanese Foundation for Cancer Research,Breast Surgical Oncology, Cancer Institute Hospital
[2] Cancer Institute of the Japanese Foundation for Cancer Research,Division of Pathology
[3] Okayama University Hospital,Breast and Endocrine Surgery
[4] Juntendo University School of Medicine,Department of Breast Oncology
[5] NHO Osaka National Hospital,Department of Surgery, Breast Oncology
[6] Graduate School of Medical Science Kumamoto University,Department of Breast and Endocrine Surgery
[7] Hokkaido University Hospital,Breast Surgery
[8] Kumamoto City Hospital,Department of Breast and Endocrine Surgery
[9] Kumamoto Shinto General Hospital,Department of Breast Surgery
[10] NHO Hokkaido Cancer Center,Department of Oncology, Immunology and Surgery
[11] Nagoya City University Graduate School of Medical Sciences,undefined
来源：
Breast Cancer | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：642 / 642
相关论文
共 50 条
  • [41] Lymph Node Metastasis Is Not Predictive of Overall Survival, Disease Free Survival, or Metastasis in Estrogen Receptor-Positive/Her2-Negative Breast Cancer
    Logan, Suzanna J.
    Sonmez, Ceyda
    Zhang, Chao
    Neely, Cameron
    Mendoza, Pia
    Arciero, Cletus
    Liu, Yuan
    Li, Xiaoxian
    MODERN PATHOLOGY, 2017, 30 : 57A - 57A
  • [42] A novel scoring system based on the clinical and genomic variables to predict the early relapse in estrogen receptor-positive/HER2-negative (ER+/HER2-) breast cancer
    Lin, Caijin
    Wu, Jiayi
    Ding, Shuning
    Andriani, Lisa
    Chen, Weilin
    Liu, Deyue
    Zhu, Li
    CANCER RESEARCH, 2020, 80 (04)
  • [43] Harmone Receptor-positive, HER2-negative Early Breast Cancer Adjuvant Use of Abemaciclib nearly halves the Incidence of Distant Metastases
    Ruedesheim, Sabine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (06)
  • [44] Prognostic significance of total choline on in-vivo proton MR spectroscopy for prediction of late recurrence in patients with hormone receptor-positive, HER2-negative early breast cancer
    Kim, Hyunjik
    Park, Heungkyu
    Chun, Yongsoon
    Kim, Hagjun
    Baek, Hyeonman
    Kim, Yunyeong
    PLOS ONE, 2025, 20 (01):
  • [45] Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the lines
    Matutino, A.
    Joy, A. A.
    Brezden-Masley, C.
    Chia, S.
    Verma, S.
    CURRENT ONCOLOGY, 2018, 25 : S131 - S141
  • [46] Sacituzumab govitecan for hormone receptor-positive HER2-negative advanced breast cancer
    Garrigos, Laia
    Camacho, Daniela
    Perez-Garcia, Jose Manuel
    Llombart-Cussac, Antonio
    Cortes, Javier
    Antonarelli, Gabriele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (10) : 949 - 958
  • [47] Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer
    Lopez-Tarruella, Sara
    Jerez, Yolanda
    Marquez-Rodas, Ivan
    Echavarria, Isabel
    Martin, Miguel
    FUTURE ONCOLOGY, 2017, 13 (24) : 2137 - 2149
  • [48] Association of mammography and ultrasound features with MammaPrint in patients with estrogen receptor-positive, HER2-negative, node-positive invasive breast cancer
    Choi, Woo Jung
    Sim, Hayan
    Kim, Hee Jeong
    Cha, Joo Hee
    Shin, Hee Jung
    Chae, Eun Young
    Kim, Hak Hee
    ACTA RADIOLOGICA, 2021, 62 (12) : 1592 - 1600
  • [49] Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
    Linnea T. Olsson
    Alina M. Hamilton
    Sarah C. Van Alsten
    Jennifer L. Lund
    Til Stürmer
    Hazel B. Nichols
    Katherine E. Reeder-Hayes
    Melissa A. Troester
    Breast Cancer Research and Treatment, 2024, 204 : 107 - 116
  • [50] Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
    Olsson, Linnea T.
    Hamilton, Alina M.
    Van Alsten, Sarah C.
    Lund, Jennifer L.
    Sturmer, Til
    Nichols, Hazel B.
    Reeder-Hayes, Katherine E.
    Troester, Melissa A.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (01) : 107 - 116
12345